nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0635	0.0986	CbGbCtD
Flecainide—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0581	0.0901	CbGbCtD
Flecainide—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.054	0.0838	CbGbCtD
Flecainide—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0459	0.0713	CbGbCtD
Flecainide—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0459	0.0713	CbGbCtD
Flecainide—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0424	0.0658	CbGbCtD
Flecainide—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.042	0.0652	CbGbCtD
Flecainide—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0409	0.0635	CbGbCtD
Flecainide—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0388	0.0601	CbGbCtD
Flecainide—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0374	0.0581	CbGbCtD
Flecainide—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0348	0.054	CbGbCtD
Flecainide—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0334	0.0518	CbGbCtD
Flecainide—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0318	0.0494	CbGbCtD
Flecainide—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0305	0.0473	CbGbCtD
Flecainide—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0235	0.0365	CbGbCtD
Flecainide—CYP2C9—Losartan—type 2 diabetes mellitus	0.0215	0.0334	CbGbCtD
Flecainide—Mefloquine—HBA2—type 2 diabetes mellitus	0.00677	0.574	CrCbGaD
Flecainide—Mefloquine—HBA1—type 2 diabetes mellitus	0.00457	0.388	CrCbGaD
Flecainide—Mefloquine—CYP3A4—type 2 diabetes mellitus	0.000453	0.0385	CrCbGaD
Flecainide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000169	0.000606	CcSEcCtD
Flecainide—Oedema—Metformin—type 2 diabetes mellitus	0.000169	0.000606	CcSEcCtD
Flecainide—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000169	0.000606	CcSEcCtD
Flecainide—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000169	0.000605	CcSEcCtD
Flecainide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000169	0.000604	CcSEcCtD
Flecainide—Flushing—Ramipril—type 2 diabetes mellitus	0.000168	0.000603	CcSEcCtD
Flecainide—Insomnia—Valsartan—type 2 diabetes mellitus	0.000168	0.000602	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000167	0.000599	CcSEcCtD
Flecainide—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000167	0.000598	CcSEcCtD
Flecainide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000167	0.000597	CcSEcCtD
Flecainide—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000167	0.000597	CcSEcCtD
Flecainide—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000167	0.000597	CcSEcCtD
Flecainide—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000167	0.000597	CcSEcCtD
Flecainide—Shock—Metformin—type 2 diabetes mellitus	0.000167	0.000596	CcSEcCtD
Flecainide—Insomnia—Orlistat—type 2 diabetes mellitus	0.000166	0.000595	CcSEcCtD
Flecainide—Malaise—Losartan—type 2 diabetes mellitus	0.000166	0.000595	CcSEcCtD
Flecainide—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000166	0.000595	CcSEcCtD
Flecainide—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000166	0.000594	CcSEcCtD
Flecainide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000166	0.000593	CcSEcCtD
Flecainide—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000166	0.000593	CcSEcCtD
Flecainide—Vertigo—Losartan—type 2 diabetes mellitus	0.000166	0.000593	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000166	0.000593	CcSEcCtD
Flecainide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000166	0.000592	CcSEcCtD
Flecainide—Somnolence—Valsartan—type 2 diabetes mellitus	0.000165	0.000592	CcSEcCtD
Flecainide—Syncope—Losartan—type 2 diabetes mellitus	0.000165	0.000591	CcSEcCtD
Flecainide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000165	0.000591	CcSEcCtD
Flecainide—Leukopenia—Losartan—type 2 diabetes mellitus	0.000165	0.00059	CcSEcCtD
Flecainide—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000165	0.00059	CcSEcCtD
Flecainide—Skin disorder—Metformin—type 2 diabetes mellitus	0.000165	0.000589	CcSEcCtD
Flecainide—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000164	0.000587	CcSEcCtD
Flecainide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000164	0.000586	CcSEcCtD
Flecainide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000164	0.000586	CcSEcCtD
Flecainide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000163	0.000584	CcSEcCtD
Flecainide—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000163	0.000584	CcSEcCtD
Flecainide—Palpitations—Losartan—type 2 diabetes mellitus	0.000163	0.000583	CcSEcCtD
Flecainide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000162	0.000581	CcSEcCtD
Flecainide—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000162	0.00058	CcSEcCtD
Flecainide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000162	0.000579	CcSEcCtD
Flecainide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000162	0.000579	CcSEcCtD
Flecainide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000162	0.000579	CcSEcCtD
Flecainide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000162	0.000579	CcSEcCtD
Flecainide—Anorexia—Metformin—type 2 diabetes mellitus	0.000161	0.000578	CcSEcCtD
Flecainide—Cough—Losartan—type 2 diabetes mellitus	0.000161	0.000576	CcSEcCtD
Flecainide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000161	0.000576	CcSEcCtD
Flecainide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000161	0.000575	CcSEcCtD
Flecainide—Alopecia—Ramipril—type 2 diabetes mellitus	0.00016	0.000574	CcSEcCtD
Flecainide—Fatigue—Valsartan—type 2 diabetes mellitus	0.00016	0.000574	CcSEcCtD
Flecainide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00016	0.000573	CcSEcCtD
Flecainide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00016	0.000573	CcSEcCtD
Flecainide—Oedema—Irbesartan—type 2 diabetes mellitus	0.00016	0.000572	CcSEcCtD
Flecainide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00016	0.000572	CcSEcCtD
Flecainide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000159	0.000571	CcSEcCtD
Flecainide—Constipation—Valsartan—type 2 diabetes mellitus	0.000159	0.000569	CcSEcCtD
Flecainide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000159	0.000568	CcSEcCtD
Flecainide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000158	0.000567	CcSEcCtD
Flecainide—Hypotension—Metformin—type 2 diabetes mellitus	0.000158	0.000566	CcSEcCtD
Flecainide—Shock—Irbesartan—type 2 diabetes mellitus	0.000157	0.000563	CcSEcCtD
Flecainide—Pain—Orlistat—type 2 diabetes mellitus	0.000157	0.000562	CcSEcCtD
Flecainide—Chest pain—Losartan—type 2 diabetes mellitus	0.000157	0.000562	CcSEcCtD
Flecainide—Arthralgia—Losartan—type 2 diabetes mellitus	0.000157	0.000562	CcSEcCtD
Flecainide—Myalgia—Losartan—type 2 diabetes mellitus	0.000157	0.000562	CcSEcCtD
Flecainide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000157	0.000561	CcSEcCtD
Flecainide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000157	0.000561	CcSEcCtD
Flecainide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000156	0.00056	CcSEcCtD
Flecainide—Anxiety—Losartan—type 2 diabetes mellitus	0.000156	0.00056	CcSEcCtD
Flecainide—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000156	0.000558	CcSEcCtD
Flecainide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000155	0.000556	CcSEcCtD
Flecainide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000155	0.000556	CcSEcCtD
Flecainide—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000155	0.000556	CcSEcCtD
Flecainide—Tension—Ramipril—type 2 diabetes mellitus	0.000155	0.000555	CcSEcCtD
Flecainide—Discomfort—Losartan—type 2 diabetes mellitus	0.000155	0.000555	CcSEcCtD
Flecainide—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000155	0.000554	CcSEcCtD
Flecainide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000155	0.000553	CcSEcCtD
Flecainide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000154	0.000553	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000154	0.000552	CcSEcCtD
Flecainide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000154	0.000552	CcSEcCtD
Flecainide—Nervousness—Ramipril—type 2 diabetes mellitus	0.000153	0.000549	CcSEcCtD
Flecainide—Dry mouth—Losartan—type 2 diabetes mellitus	0.000153	0.000549	CcSEcCtD
Flecainide—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000152	0.000545	CcSEcCtD
Flecainide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000152	0.000544	CcSEcCtD
Flecainide—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000152	0.000544	CcSEcCtD
Flecainide—Confusional state—Losartan—type 2 diabetes mellitus	0.000152	0.000543	CcSEcCtD
Flecainide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000151	0.000542	CcSEcCtD
Flecainide—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000151	0.00054	CcSEcCtD
Flecainide—Somnolence—Metformin—type 2 diabetes mellitus	0.000151	0.000539	CcSEcCtD
Flecainide—Oedema—Losartan—type 2 diabetes mellitus	0.00015	0.000538	CcSEcCtD
Flecainide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00015	0.000538	CcSEcCtD
Flecainide—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000149	0.000534	CcSEcCtD
Flecainide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000149	0.000534	CcSEcCtD
Flecainide—Tremor—Ramipril—type 2 diabetes mellitus	0.000148	0.00053	CcSEcCtD
Flecainide—Shock—Losartan—type 2 diabetes mellitus	0.000148	0.00053	CcSEcCtD
Flecainide—Urticaria—Valsartan—type 2 diabetes mellitus	0.000148	0.000529	CcSEcCtD
Flecainide—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000148	0.000528	CcSEcCtD
Flecainide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000147	0.000527	CcSEcCtD
Flecainide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000147	0.000527	CcSEcCtD
Flecainide—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000147	0.000526	CcSEcCtD
Flecainide—Tachycardia—Losartan—type 2 diabetes mellitus	0.000147	0.000525	CcSEcCtD
Flecainide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000147	0.000525	CcSEcCtD
Flecainide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000146	0.000524	CcSEcCtD
Flecainide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000146	0.000523	CcSEcCtD
Flecainide—Fatigue—Metformin—type 2 diabetes mellitus	0.000146	0.000523	CcSEcCtD
Flecainide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000146	0.000522	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000146	0.000521	CcSEcCtD
Flecainide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000145	0.00052	CcSEcCtD
Flecainide—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000145	0.00052	CcSEcCtD
Flecainide—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000145	0.00052	CcSEcCtD
Flecainide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000145	0.00052	CcSEcCtD
Flecainide—Constipation—Metformin—type 2 diabetes mellitus	0.000145	0.000518	CcSEcCtD
Flecainide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000144	0.000514	CcSEcCtD
Flecainide—Anorexia—Losartan—type 2 diabetes mellitus	0.000143	0.000513	CcSEcCtD
Flecainide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000143	0.000513	CcSEcCtD
Flecainide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000143	0.000513	CcSEcCtD
Flecainide—Malaise—Ramipril—type 2 diabetes mellitus	0.000143	0.00051	CcSEcCtD
Flecainide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000142	0.00051	CcSEcCtD
Flecainide—Rash—Glyburide—type 2 diabetes mellitus	0.000142	0.000509	CcSEcCtD
Flecainide—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000142	0.000509	CcSEcCtD
Flecainide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000142	0.000508	CcSEcCtD
Flecainide—Vertigo—Ramipril—type 2 diabetes mellitus	0.000142	0.000508	CcSEcCtD
Flecainide—Syncope—Ramipril—type 2 diabetes mellitus	0.000142	0.000507	CcSEcCtD
Flecainide—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000141	0.000506	CcSEcCtD
Flecainide—Headache—Glyburide—type 2 diabetes mellitus	0.000141	0.000505	CcSEcCtD
Flecainide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000141	0.000504	CcSEcCtD
Flecainide—Hypotension—Losartan—type 2 diabetes mellitus	0.000141	0.000503	CcSEcCtD
Flecainide—Palpitations—Ramipril—type 2 diabetes mellitus	0.00014	0.0005	CcSEcCtD
Flecainide—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00014	0.000499	CcSEcCtD
Flecainide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000139	0.000497	CcSEcCtD
Flecainide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000139	0.000497	CcSEcCtD
Flecainide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000139	0.000496	CcSEcCtD
Flecainide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000138	0.000496	CcSEcCtD
Flecainide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000138	0.000494	CcSEcCtD
Flecainide—Cough—Ramipril—type 2 diabetes mellitus	0.000138	0.000494	CcSEcCtD
Flecainide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000138	0.000493	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000137	0.00049	CcSEcCtD
Flecainide—Convulsion—Ramipril—type 2 diabetes mellitus	0.000137	0.00049	CcSEcCtD
Flecainide—Pain—Irbesartan—type 2 diabetes mellitus	0.000137	0.000489	CcSEcCtD
Flecainide—Constipation—Irbesartan—type 2 diabetes mellitus	0.000137	0.000489	CcSEcCtD
Flecainide—Insomnia—Losartan—type 2 diabetes mellitus	0.000136	0.000487	CcSEcCtD
Flecainide—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000135	0.000483	CcSEcCtD
Flecainide—Urticaria—Metformin—type 2 diabetes mellitus	0.000135	0.000482	CcSEcCtD
Flecainide—Myalgia—Ramipril—type 2 diabetes mellitus	0.000135	0.000481	CcSEcCtD
Flecainide—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000135	0.000481	CcSEcCtD
Flecainide—Chest pain—Ramipril—type 2 diabetes mellitus	0.000135	0.000481	CcSEcCtD
Flecainide—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000134	0.00048	CcSEcCtD
Flecainide—Anxiety—Ramipril—type 2 diabetes mellitus	0.000134	0.00048	CcSEcCtD
Flecainide—Nausea—Glyburide—type 2 diabetes mellitus	0.000134	0.000479	CcSEcCtD
Flecainide—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000134	0.000479	CcSEcCtD
Flecainide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000134	0.000479	CcSEcCtD
Flecainide—Somnolence—Losartan—type 2 diabetes mellitus	0.000134	0.000479	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000134	0.000478	CcSEcCtD
Flecainide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000133	0.000478	CcSEcCtD
Flecainide—Discomfort—Ramipril—type 2 diabetes mellitus	0.000133	0.000476	CcSEcCtD
Flecainide—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000132	0.000474	CcSEcCtD
Flecainide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000132	0.000472	CcSEcCtD
Flecainide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000132	0.000471	CcSEcCtD
Flecainide—Pruritus—Valsartan—type 2 diabetes mellitus	0.000132	0.000471	CcSEcCtD
Flecainide—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000132	0.000471	CcSEcCtD
Flecainide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000131	0.000468	CcSEcCtD
Flecainide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000131	0.000468	CcSEcCtD
Flecainide—Confusional state—Ramipril—type 2 diabetes mellitus	0.00013	0.000465	CcSEcCtD
Flecainide—Pruritus—Orlistat—type 2 diabetes mellitus	0.00013	0.000465	CcSEcCtD
Flecainide—Fatigue—Losartan—type 2 diabetes mellitus	0.00013	0.000464	CcSEcCtD
Flecainide—Oedema—Ramipril—type 2 diabetes mellitus	0.000129	0.000462	CcSEcCtD
Flecainide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000129	0.000461	CcSEcCtD
Flecainide—Constipation—Losartan—type 2 diabetes mellitus	0.000129	0.00046	CcSEcCtD
Flecainide—Pain—Losartan—type 2 diabetes mellitus	0.000129	0.00046	CcSEcCtD
Flecainide—Rash—Gliclazide—type 2 diabetes mellitus	0.000128	0.000457	CcSEcCtD
Flecainide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000128	0.000456	CcSEcCtD
Flecainide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000127	0.000455	CcSEcCtD
Flecainide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000127	0.000454	CcSEcCtD
Flecainide—Shock—Ramipril—type 2 diabetes mellitus	0.000127	0.000454	CcSEcCtD
Flecainide—Headache—Gliclazide—type 2 diabetes mellitus	0.000127	0.000454	CcSEcCtD
Flecainide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000126	0.000453	CcSEcCtD
Flecainide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000126	0.000452	CcSEcCtD
Flecainide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000126	0.000452	CcSEcCtD
Flecainide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000126	0.000452	CcSEcCtD
Flecainide—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000126	0.00045	CcSEcCtD
Flecainide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000126	0.00045	CcSEcCtD
Flecainide—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000125	0.000448	CcSEcCtD
Flecainide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000125	0.000446	CcSEcCtD
Flecainide—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000124	0.000444	CcSEcCtD
Flecainide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000123	0.00044	CcSEcCtD
Flecainide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000123	0.00044	CcSEcCtD
Flecainide—Anorexia—Ramipril—type 2 diabetes mellitus	0.000123	0.00044	CcSEcCtD
Flecainide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000122	0.000435	CcSEcCtD
Flecainide—Asthenia—Metformin—type 2 diabetes mellitus	0.000122	0.000435	CcSEcCtD
Flecainide—Hypotension—Ramipril—type 2 diabetes mellitus	0.000121	0.000431	CcSEcCtD
Flecainide—Nausea—Gliclazide—type 2 diabetes mellitus	0.00012	0.00043	CcSEcCtD
Flecainide—Pruritus—Metformin—type 2 diabetes mellitus	0.00012	0.000429	CcSEcCtD
Flecainide—Urticaria—Losartan—type 2 diabetes mellitus	0.000119	0.000428	CcSEcCtD
Flecainide—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000119	0.000426	CcSEcCtD
Flecainide—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000119	0.000426	CcSEcCtD
Flecainide—Vomiting—Valsartan—type 2 diabetes mellitus	0.000118	0.000423	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000118	0.000421	CcSEcCtD
Flecainide—Rash—Valsartan—type 2 diabetes mellitus	0.000117	0.00042	CcSEcCtD
Flecainide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000117	0.000419	CcSEcCtD
Flecainide—Vomiting—Orlistat—type 2 diabetes mellitus	0.000117	0.000418	CcSEcCtD
Flecainide—Insomnia—Ramipril—type 2 diabetes mellitus	0.000117	0.000417	CcSEcCtD
Flecainide—Headache—Valsartan—type 2 diabetes mellitus	0.000117	0.000417	CcSEcCtD
Flecainide—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000116	0.000415	CcSEcCtD
Flecainide—Rash—Orlistat—type 2 diabetes mellitus	0.000116	0.000415	CcSEcCtD
Flecainide—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000116	0.000414	CcSEcCtD
Flecainide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000116	0.000414	CcSEcCtD
Flecainide—Headache—Orlistat—type 2 diabetes mellitus	0.000115	0.000412	CcSEcCtD
Flecainide—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000115	0.000412	CcSEcCtD
Flecainide—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000115	0.00041	CcSEcCtD
Flecainide—Somnolence—Ramipril—type 2 diabetes mellitus	0.000115	0.00041	CcSEcCtD
Flecainide—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000114	0.000406	CcSEcCtD
Flecainide—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000113	0.000405	CcSEcCtD
Flecainide—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000112	0.000401	CcSEcCtD
Flecainide—Dizziness—Metformin—type 2 diabetes mellitus	0.000112	0.000401	CcSEcCtD
Flecainide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000111	0.000398	CcSEcCtD
Flecainide—Fatigue—Ramipril—type 2 diabetes mellitus	0.000111	0.000398	CcSEcCtD
Flecainide—Nausea—Valsartan—type 2 diabetes mellitus	0.00011	0.000395	CcSEcCtD
Flecainide—Constipation—Ramipril—type 2 diabetes mellitus	0.00011	0.000395	CcSEcCtD
Flecainide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000109	0.000391	CcSEcCtD
Flecainide—Nausea—Orlistat—type 2 diabetes mellitus	0.000109	0.000391	CcSEcCtD
Flecainide—Asthenia—Losartan—type 2 diabetes mellitus	0.000108	0.000386	CcSEcCtD
Flecainide—Vomiting—Metformin—type 2 diabetes mellitus	0.000108	0.000385	CcSEcCtD
Flecainide—Rash—Metformin—type 2 diabetes mellitus	0.000107	0.000382	CcSEcCtD
Flecainide—Dermatitis—Metformin—type 2 diabetes mellitus	0.000107	0.000382	CcSEcCtD
Flecainide—Pruritus—Losartan—type 2 diabetes mellitus	0.000106	0.000381	CcSEcCtD
Flecainide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000106	0.00038	CcSEcCtD
Flecainide—Headache—Metformin—type 2 diabetes mellitus	0.000106	0.00038	CcSEcCtD
Flecainide—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000106	0.000378	CcSEcCtD
Flecainide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000105	0.000377	CcSEcCtD
Flecainide—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000103	0.000368	CcSEcCtD
Flecainide—Urticaria—Ramipril—type 2 diabetes mellitus	0.000102	0.000367	CcSEcCtD
Flecainide—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000102	0.000365	CcSEcCtD
Flecainide—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000102	0.000365	CcSEcCtD
Flecainide—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000102	0.000364	CcSEcCtD
Flecainide—Rash—Irbesartan—type 2 diabetes mellitus	0.000101	0.000361	CcSEcCtD
Flecainide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000101	0.00036	CcSEcCtD
Flecainide—Nausea—Metformin—type 2 diabetes mellitus	0.000101	0.00036	CcSEcCtD
Flecainide—Headache—Irbesartan—type 2 diabetes mellitus	0.0001	0.000358	CcSEcCtD
Flecainide—Dizziness—Losartan—type 2 diabetes mellitus	9.95e-05	0.000356	CcSEcCtD
Flecainide—Vomiting—Losartan—type 2 diabetes mellitus	9.56e-05	0.000342	CcSEcCtD
Flecainide—Nausea—Irbesartan—type 2 diabetes mellitus	9.49e-05	0.00034	CcSEcCtD
Flecainide—Rash—Losartan—type 2 diabetes mellitus	9.48e-05	0.000339	CcSEcCtD
Flecainide—Dermatitis—Losartan—type 2 diabetes mellitus	9.48e-05	0.000339	CcSEcCtD
Flecainide—Headache—Losartan—type 2 diabetes mellitus	9.42e-05	0.000337	CcSEcCtD
Flecainide—Asthenia—Ramipril—type 2 diabetes mellitus	9.25e-05	0.000331	CcSEcCtD
Flecainide—Pruritus—Ramipril—type 2 diabetes mellitus	9.13e-05	0.000327	CcSEcCtD
Flecainide—Nausea—Losartan—type 2 diabetes mellitus	8.93e-05	0.00032	CcSEcCtD
Flecainide—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.82e-05	0.000316	CcSEcCtD
Flecainide—Dizziness—Ramipril—type 2 diabetes mellitus	8.53e-05	0.000305	CcSEcCtD
Flecainide—Vomiting—Ramipril—type 2 diabetes mellitus	8.2e-05	0.000293	CcSEcCtD
Flecainide—Rash—Ramipril—type 2 diabetes mellitus	8.13e-05	0.000291	CcSEcCtD
Flecainide—Dermatitis—Ramipril—type 2 diabetes mellitus	8.12e-05	0.000291	CcSEcCtD
Flecainide—Headache—Ramipril—type 2 diabetes mellitus	8.08e-05	0.000289	CcSEcCtD
Flecainide—Nausea—Ramipril—type 2 diabetes mellitus	7.66e-05	0.000274	CcSEcCtD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	6.86e-05	0.00107	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—AKT2—type 2 diabetes mellitus	6.75e-05	0.00105	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—LPL—type 2 diabetes mellitus	6.61e-05	0.00103	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	6.45e-05	0.001	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—CYP2E1—type 2 diabetes mellitus	6.44e-05	0.001	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—CYP2E1—type 2 diabetes mellitus	6.38e-05	0.000993	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—CYP1A2—type 2 diabetes mellitus	6.36e-05	0.00099	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	6.35e-05	0.000988	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—SRC—type 2 diabetes mellitus	6.35e-05	0.000988	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—CYP1A2—type 2 diabetes mellitus	6.31e-05	0.000982	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	6.29e-05	0.000979	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—CD36—type 2 diabetes mellitus	6.28e-05	0.000978	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	6.28e-05	0.000977	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	6.22e-05	0.000968	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—CYP3A4—type 2 diabetes mellitus	6.21e-05	0.000966	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—VEGFA—type 2 diabetes mellitus	6.18e-05	0.000962	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—CYP3A4—type 2 diabetes mellitus	6.15e-05	0.000958	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	6.12e-05	0.000953	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	6.07e-05	0.000944	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PPARA—type 2 diabetes mellitus	5.84e-05	0.000909	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—RELA—type 2 diabetes mellitus	5.76e-05	0.000897	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—EGFR—type 2 diabetes mellitus	5.56e-05	0.000866	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—LEP—type 2 diabetes mellitus	5.54e-05	0.000862	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	5.34e-05	0.000831	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	5.2e-05	0.00081	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	5.2e-05	0.000809	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	4.96e-05	0.000772	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	4.96e-05	0.000772	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	4.96e-05	0.000772	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—MMP9—type 2 diabetes mellitus	4.91e-05	0.000765	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—GSTM1—type 2 diabetes mellitus	4.88e-05	0.000759	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—NFKB1—type 2 diabetes mellitus	4.86e-05	0.000757	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—GSTM1—type 2 diabetes mellitus	4.84e-05	0.000753	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PPARG—type 2 diabetes mellitus	4.83e-05	0.000751	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	4.81e-05	0.000749	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	4.77e-05	0.000742	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—INS—type 2 diabetes mellitus	4.73e-05	0.000737	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—MMP9—type 2 diabetes mellitus	4.67e-05	0.000726	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—AKT2—type 2 diabetes mellitus	4.58e-05	0.000712	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—SRC—type 2 diabetes mellitus	4.53e-05	0.000705	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	4.5e-05	0.0007	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	4.42e-05	0.000688	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—VEGFA—type 2 diabetes mellitus	4.41e-05	0.000687	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—SRC—type 2 diabetes mellitus	4.3e-05	0.00067	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—IL6—type 2 diabetes mellitus	4.28e-05	0.000665	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—VEGFA—type 2 diabetes mellitus	4.19e-05	0.000652	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—TGFB1—type 2 diabetes mellitus	4.05e-05	0.00063	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—EGFR—type 2 diabetes mellitus	3.97e-05	0.000618	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—RELA—type 2 diabetes mellitus	3.91e-05	0.000608	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—TNF—type 2 diabetes mellitus	3.78e-05	0.000588	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—EGFR—type 2 diabetes mellitus	3.77e-05	0.000587	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	3.76e-05	0.000585	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	3.76e-05	0.000585	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—BHMT—type 2 diabetes mellitus	3.72e-05	0.000579	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—BHMT—type 2 diabetes mellitus	3.69e-05	0.000574	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MMP9—type 2 diabetes mellitus	3.33e-05	0.000518	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—NFKB1—type 2 diabetes mellitus	3.3e-05	0.000513	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTGDS—type 2 diabetes mellitus	3.25e-05	0.000506	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AANAT—type 2 diabetes mellitus	3.25e-05	0.000506	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AANAT—type 2 diabetes mellitus	3.22e-05	0.000502	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTGDS—type 2 diabetes mellitus	3.22e-05	0.000502	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CDO1—type 2 diabetes mellitus	3.08e-05	0.00048	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GPD2—type 2 diabetes mellitus	3.08e-05	0.00048	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—SRC—type 2 diabetes mellitus	3.07e-05	0.000478	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	3.07e-05	0.000477	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GPD2—type 2 diabetes mellitus	3.06e-05	0.000476	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CDO1—type 2 diabetes mellitus	3.06e-05	0.000476	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—IL6—type 2 diabetes mellitus	3.05e-05	0.000475	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—VEGFA—type 2 diabetes mellitus	2.99e-05	0.000465	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	2.99e-05	0.000465	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	2.97e-05	0.000462	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AK1—type 2 diabetes mellitus	2.94e-05	0.000458	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AK1—type 2 diabetes mellitus	2.92e-05	0.000454	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—IL6—type 2 diabetes mellitus	2.9e-05	0.000451	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	2.88e-05	0.000448	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—AKT1—type 2 diabetes mellitus	2.82e-05	0.000438	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—TGFB1—type 2 diabetes mellitus	2.75e-05	0.000427	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC5A4—type 2 diabetes mellitus	2.71e-05	0.000422	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MAT1A—type 2 diabetes mellitus	2.71e-05	0.000422	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—EGFR—type 2 diabetes mellitus	2.69e-05	0.000419	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	2.69e-05	0.000419	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	2.69e-05	0.000419	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	2.68e-05	0.000417	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	2.63e-05	0.000409	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HBA2—type 2 diabetes mellitus	2.62e-05	0.000408	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—G6PC—type 2 diabetes mellitus	2.62e-05	0.000408	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ENPP1—type 2 diabetes mellitus	2.62e-05	0.000408	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.62e-05	0.000408	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ND1—type 2 diabetes mellitus	2.62e-05	0.000408	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	2.61e-05	0.000406	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	2.6e-05	0.000404	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	2.6e-05	0.000404	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	2.6e-05	0.000404	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	2.6e-05	0.000404	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.6e-05	0.000404	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—TNF—type 2 diabetes mellitus	2.56e-05	0.000399	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	2.54e-05	0.000395	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	2.52e-05	0.000392	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	2.42e-05	0.000377	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	2.4e-05	0.000373	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	2.4e-05	0.000373	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	2.38e-05	0.00037	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	2.38e-05	0.00037	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	2.34e-05	0.000364	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	2.32e-05	0.00036	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	2.23e-05	0.000347	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	2.23e-05	0.000347	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	2.23e-05	0.000347	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	2.21e-05	0.000344	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	2.21e-05	0.000344	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	2.21e-05	0.000344	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	2.14e-05	0.000333	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	2.14e-05	0.000333	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	2.12e-05	0.00033	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	2.12e-05	0.00033	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—IL6—type 2 diabetes mellitus	2.07e-05	0.000322	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	2.06e-05	0.00032	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	2.06e-05	0.00032	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	2.04e-05	0.000317	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	2.04e-05	0.000317	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	2.02e-05	0.000314	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	2e-05	0.000312	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2e-05	0.000312	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	1.99e-05	0.000309	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	1.99e-05	0.000309	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	1.99e-05	0.000309	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.97e-05	0.000306	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.97e-05	0.000306	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.97e-05	0.000306	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.91e-05	0.000297	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—AKT1—type 2 diabetes mellitus	1.91e-05	0.000297	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.87e-05	0.000291	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.85e-05	0.000288	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.82e-05	0.000284	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.78e-05	0.000277	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	1.75e-05	0.000272	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.73e-05	0.00027	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.73e-05	0.00027	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.69e-05	0.000263	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.69e-05	0.000263	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.69e-05	0.000263	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.69e-05	0.000263	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	1.67e-05	0.000261	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	1.67e-05	0.000261	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	1.67e-05	0.000261	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	1.67e-05	0.000261	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1.62e-05	0.000252	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.61e-05	0.000251	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	1.61e-05	0.00025	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.56e-05	0.000243	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.53e-05	0.000238	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.51e-05	0.000235	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	1.51e-05	0.000234	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	1.49e-05	0.000232	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.41e-05	0.000219	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.39e-05	0.000217	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	1.38e-05	0.000214	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	1.38e-05	0.000214	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.37e-05	0.000212	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.37e-05	0.000212	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	1.35e-05	0.00021	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	1.34e-05	0.000209	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	1.34e-05	0.000209	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	1.34e-05	0.000209	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.34e-05	0.000208	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.33e-05	0.000208	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.33e-05	0.000207	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.33e-05	0.000207	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.33e-05	0.000207	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.33e-05	0.000207	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.32e-05	0.000206	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.31e-05	0.000204	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.3e-05	0.000202	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	1.29e-05	0.000201	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.28e-05	0.0002	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	1.2e-05	0.000187	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	1.2e-05	0.000187	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	1.2e-05	0.000187	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.2e-05	0.000186	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.19e-05	0.000186	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.19e-05	0.000186	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.19e-05	0.000186	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	1.18e-05	0.000184	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.17e-05	0.000182	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	1.17e-05	0.000182	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.16e-05	0.000181	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.15e-05	0.000178	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.14e-05	0.000178	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.14e-05	0.000177	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.1e-05	0.000171	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.09e-05	0.00017	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.09e-05	0.000169	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.09e-05	0.000169	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.08e-05	0.000168	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.08e-05	0.000168	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.06e-05	0.000165	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.05e-05	0.000164	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.05e-05	0.000163	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.04e-05	0.000162	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.04e-05	0.000162	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.03e-05	0.000161	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.03e-05	0.000161	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	8.99e-06	0.00014	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.99e-06	0.00014	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	8.95e-06	0.000139	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	8.92e-06	0.000139	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.92e-06	0.000139	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	8.88e-06	0.000138	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	8.83e-06	0.000137	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	8.76e-06	0.000136	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	8.58e-06	0.000133	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	8.5e-06	0.000132	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	8.34e-06	0.00013	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	8.27e-06	0.000129	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	8.19e-06	0.000127	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	8.12e-06	0.000126	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	8.02e-06	0.000125	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	7.99e-06	0.000124	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	7.95e-06	0.000124	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	7.92e-06	0.000123	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	7.78e-06	0.000121	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	7.71e-06	0.00012	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	7.68e-06	0.00012	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	7.62e-06	0.000119	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	7.37e-06	0.000115	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	7.31e-06	0.000114	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	7.23e-06	0.000113	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	7.17e-06	0.000112	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	7.01e-06	0.000109	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	6.94e-06	0.000108	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	6.89e-06	0.000107	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	6.86e-06	0.000107	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	6.83e-06	0.000106	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	6.8e-06	0.000106	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	6.79e-06	0.000106	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	6.73e-06	0.000105	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	5.98e-06	9.3e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	5.93e-06	9.22e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	5.86e-06	9.13e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	5.81e-06	9.05e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	5.38e-06	8.37e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	5.33e-06	8.29e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.14e-06	8e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	5.14e-06	8e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	5.1e-06	7.93e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	5.1e-06	7.93e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	4.7e-06	7.32e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	4.66e-06	7.26e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.36e-06	3.68e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.34e-06	3.65e-05	CbGpPWpGaD
